Please login to the form below

Not currently logged in
Email:
Password:

Aptuit invests USD 100m in Laurus Labs

Aptuit and Laurus Labs have formed a contract drug development company, Aptuit Laurus, in India

Global contract drug development firm Aptuit and India-based Laurus Labs have formed a contract drug development company, Aptuit Laurus, in India.

Aptuit says it will invest over USD 100m over the next four years to ensure the development of Aptuit Laurus' manufacturing and informatics capabilities.

The new company will combine Aptuit's global offerings in drug development with Laurus' R&D and manufacturing expertise and newly built facilities to provide established and emerging pharmaceutical companies with integrated services, technologies and manufacturing capabilities that span the entire drug development lifecycle.

Aptuit Laurus will be based in Hyderabad with additional facilities in Vishakhapatnam and Bangalore and will initially provide services to clients in early-stage drug discovery, medicinal chemistry, lead optimisation, process development, scale-up and process optimisation, safety and hazard assessment, formulation development and analytical chemistry.

The new company will comprise Laurus' newly-established 14,864.5 square-metre R&D facility in Hyderabad, which already employs over 200 scientific personnel. It will also include Laurus' large-scale manufacturing plant, which is currently under construction on over 13.8 hectares of land in Pharma City, Vishakhapatnam. The new firm will also use Aptuit's existing Informatics Development and Support group of 100 employees in Bangalore.

20th June 2007

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...
Article: What's next? How behavioural science can support pharma's future
...
Video: UX/ Experience design research
...

Infographics